Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Efalizumab

Copy Product Info
😃Good
Catalog No. T76924Cas No. 214745-43-4
Alias Hu1124, HU 1124

Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 α subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinocytes, and can be used to study plaque psoriasis and psoriatic arthritis.

Efalizumab

Efalizumab

Copy Product Info
😃Good
Catalog No. T76924Alias Hu1124, HU 1124Cas No. 214745-43-4
Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 α subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinocytes, and can be used to study plaque psoriasis and psoriatic arthritis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$198In StockIn Stock
5 mg$513In StockIn Stock
10 mg$819-In Stock
25 mg$1,220-In Stock
50 mg$1,630-In Stock
100 mg$2,220-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.77% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 α subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinocytes, and can be used to study plaque psoriasis and psoriatic arthritis.
In vitro
Efalizumab, at concentrations ranging from 78 ng/mL to 5 mg/mL, promotes leukocytosis and reduces the expression of LFA-1 on T cells within the peripheral blood. Additionally, at the same concentration levels, it inhibits the proliferation of peripheral blood mononuclear cells (PBMC) that is stimulated by plate-bound anti-CD3.
In vivo
Efalizumab exhibits side effects including bacterial sepsis, viral meningitis, invasive fungal disease, and progressive multifocal leukoencephalopathy (PML), a brain infection caused by the reactivation of latent JC virus infection[2].
SynonymsHu1124, HU 1124
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetIntegrin aL/ITGAL/CD11a
Chemical Properties
Molecular Weight146.14 kDa
Cas No.214745-43-4
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Efalizumab | purchase Efalizumab | Efalizumab cost | order Efalizumab | Efalizumab in vivo | Efalizumab in vitro | Efalizumab molecular weight